"Excipients Utilized in the Formulation and Development of Bilayer Tablet Systems"
AbstractBilayer tablets are sophisticated solid oral dosage forms designed to deliver two separate activepharmaceutical ingredients (APIs) or formulations in one tablet. Each layer can be specificallydesigned to release its medication at different rates, such as immediate or sustained release,allowing for precise control over the drug's pharmacokinetic profile. This two-layer design isespecially beneficial in combination therapies, where one API can provide quick relief, whilethe other is released gradually for extended therapeutic benefits. Such tailored drug releaseimproves patient adherence, reduces side effects, and enhances overall therapeuticeffectiveness. Bilayer tablets are particularly effective for combining drugs that have varyingsolubility characteristics or mechanisms of action, leading to better therapeutic results. Theexcipients used in bilayer tablets play a crucial role in achieving the desired release profilesand securing the stability of the formulation. Typical excipients include binders, lubricants,disintegrants, and fillers. Binders like hydroxypropyl cellulose (HPC) or polyvinylpyrrolidone(PVP) help maintain the tablet's mechanical strength, while lubricants such as magnesiumstearate reduce friction during the compression process. Disintegrants, including sodium starchglycolate, aid in breaking down the tablet in the gastrointestinal tract, thus ensuring effectivedrug release. Fillers like microcrystalline cellulose (MCC) add bulk to the tablet, facilitatingoptimal delivery of active ingredients. Additionally, controlled-release polymers, such as ethylcellulose, are often employed to manage the drug release rate. These excipients enhance thestability and functionality of both the immediate and sustained-release layers, improving themanufacturing process and optimizing therapeutic outcomes. Bilayer tablets are becomingincreasingly important in treating chronic conditions and disorders that necessitate precise orprolonged drug delivery.
Institutions
- IPS Academy (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-06-23
- DOI
- https://doi.org/10.5281/zenodo.15721491
- Primary Topic
- Drug Solubulity and Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00